logo
Plus   Neg
Share
Email

Qualcomm Projects Q2 Adj. EPS To Decline 44% - 51% YoY

Qualcomm (QCOM) announced the company expects second-quarter non-GAAP EPS to be in a range of $0.65 - $0.75, a year-over-year change of 44% - 51% from $1.34. Revenues are projected to be in the range of $4.8 - $5.6 billion (decrease 4% - increase 12% from prior year). Qualcomm noted that its financial guidance for the second quarter of fiscal 2018 excludes QTL revenues for royalties due on the sale of Apple products by Apple's contract manufacturers, as well as the sale of products by the other licensee in dispute as the company expects the actions taken by these licensees will continue until the respective disputes are resolved. The company has not included estimates related to the operating results of the proposed acquisition of NXP in its second-quarter outlook.

For fiscal 2019, the company anticipates non-GAAP EPS in a range of $6.75 - $7.50 (Fiscal 2019 accretion from NXP anticipated at $1.50). Fiscal 2019 non-GAAP EPS, before impact of expected licensing resolutions, is projected at $5.25.

On January 16, 2018, Qualcomm announced a cost reduction plan. As part of the plan, the company will implement a series of targeted reductions to reduce annual costs by $1 billion. The company expects these cost reductions to be fully captured in fiscal 2019 results.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory... Hu Products has recalled a single production lot of the Hu Chocolate Covered Hunks - Sour Goldenberries Product citing the possible presence of undeclared almonds, an allergen, the U.S. Food and Drug Administration said. The recall involves 4 oz. bags of the Hu Chocolate Covered Hunks - Sour Goldenberries with UPC code of 850180006510, Best By Date of 08/2021, and Lot Code of 202891.
Follow RTT